Roster of the Hematology and Pathology Devices Panel
Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including pathology, hematology, histopathology, cytotechnology and molecular biology and makes appropriate recommendations to the Commissioner of Food and Drugs.
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 4
Lydia P. Howell, M.D.
Expertise: Cytopathology; Pathology
Term: 03/01/2011 – 02/28/2015
Professor of Pathology & Lab Medicine
Acting Chair, Dept. of Pathology & Lab Medicine
Univ. of California, Davis Medical Center
4400 V Street
Sacramento, CA 95817
|Designated Federal Official|
Sara J. Anderson
LCDR, US Public Health Service
Center for Devices and Radiological Health
Office of Device Evaluation
10903 New Hampshire Ave.
WO Bldg. 66, Room #1544
Silver Spring, MD 20903
**Charlotte A. Brown, Ph.D.
*Margaret O. Roberts Davis, Ph.D., J.D.
Louis A. DePalma, M.D.
Dina R. Mody, M.D.